Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-28 @ 9:14 AM
Study NCT ID:
NCT00477269
Status:
COMPLETED
Last Update Posted:
2015-03-23
First Post:
2007-05-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2014-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-22
First Submit QC Date:
None
Study First Post Date:
2007-05-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-26
Results First Submit QC Date:
None
Results First Post Date:
2015-03-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-10
Last Update Post Date:
2015-03-23
Last Update Post Date Type:
ESTIMATED